Recent COVID Data

At Adaptive, we are leveraging the immune system’s natural ability to detect and treat disease to develop clinical products. Understanding the immune response to COVID-19 may lead to solutions to accelerate progress against the disease.

Damon H. May1 , Benjamin E. R. Rubin1 , Sudeb C. Dalai1,2 , Krishna Patel1 , Shahin Shafiani1 , Rebecca Elyanow1 , Matthew T. Noakes1 , Thomas M. Snyder1 , and Harlan S. Robins1

1 Adaptive Biotechnologies, Seattle, Washington, USA
2 Stanford University School of Medicine, Stanford, California, USA